Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
GSK progresses regulatory filings for treating COPD with mepolizumabthis in 2017
September 12, 2017 Off

GSK progresses regulatory filings for treating COPD with mepolizumabthis in 2017

By Dino Mustafić

GlaxoSmithKline has published full results from the phase III studies for mepolizumab in chronic obstructive pulmonary disease (COPD). For people living…

HanAll Biopharma, Harbour BioMed team up to make and sell dry eye and other inflammatory diseases products
September 12, 2017 Off

HanAll Biopharma, Harbour BioMed team up to make and sell dry eye and other inflammatory diseases products

By Dino Mustafić

HanAll Biopharma and Harbour BioMed on Tuesday announced agreeing to produce and sell HanAll’s two novel biologics, in Greater China, including Hong Kong, Macau and Taiwan,…

September 12, 2017 Off

Cardiome Pharmato to sell Basilea Pharmaceutica’s antibiotic in Nordic Europe and Israel

By Dino Mustafić

Basilea Pharmaceutica’s Basilea Pharmaceutica International Ltd. has entered into a distribution agreement with Cardiome Pharma Corp. for Basilea’s antibiotic Zevtera/Mabelio (ceftobiprole) in Europe (excluding Nordic countries) and Israel.

Sandoz proposed biosimilar rituximab accepted for review by the FDA
September 12, 2017 Off

Sandoz proposed biosimilar rituximab accepted for review by the FDA

By Dino Mustafić

Rituxan is used to treat blood cancers including non-Hodgkin’s lymphoma (follicular lymphoma and diffuse large B-cell lymphoma) and chronic lymphocytic leukemia, as well as immunological diseases such as rheumatoid arthritis.

TiGenix CEO welcomes two new team members in US
September 12, 2017 Off

TiGenix CEO welcomes two new team members in US

By Dino Mustafić

Belgian biopharmaceutical stem cells focused company TiGenix NV has made two senior appointments to reinforce its U.S. operations, who will both…

September 11, 2017 Off

Piramal Pharma Solutions name chief operating officer

By Dino Mustafić

Piramal Pharma Solutions (PPS), part of Piramal Enterprises Limited, has appointed John Fowler as its Chief Operating Officer last week. Fowler…

Santhera enrolls first n Duchenne Muscular Dystrophy patients in Raxone study
September 11, 2017 Off

Santhera enrolls first n Duchenne Muscular Dystrophy patients in Raxone study

By Dino Mustafić

Santhera Pharmaceuticals has enrolled first DMD patients with respiratory function decline not taking glucocorticoids into UK’s Early Access to Medicines…

Sanofi, Regeneron’s asthma study meets two primary endpoints
September 11, 2017 Off

Sanofi, Regeneron’s asthma study meets two primary endpoints

By Dino Mustafić

The pivotal Phase 3 Libery ASthma Quest study of dupilumab in a broad population of patients with uncontrolled, persistent asthma…

September 11, 2017 Off

Targovax with three oncology posters at ESMO in Spain

By Dino Mustafić

Targovax ASA, a clinical stage company focused on immuno-oncology therapies against solid tumors, on Monday revealed that three posters were…

Piramal Pharma Solutions names new Chief Operating Officer
September 8, 2017 Off

Piramal Pharma Solutions names new Chief Operating Officer

By Dino Mustafić

India-based Piramal Pharma Solutions (PPS), part of Piramal Enterprises Limited, has named John Fowler as its Chief Operating Officer. In announcing…

Posts pagination

Previous 1 … 3,435 3,436 3,437 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine